Not much has been reported on these cytosolic homologues in the vascular system, and data in knockout mice are totally lacking. In fact, to our knowledge, a NoxA1 knockout mouse has not yet been generated. NoxA1 is expressed in smooth muscle cells and substitutes for p67phox. 9, 10 For NoxO1, a role of streptozotocin diabetes mellitus-induced eNOS uncoupling has been suggested on the basis of in vivo siRNA experiments. 11 Moreover, NoxO1 is induced by oscillatory flow and contributes to superoxide anion (O 2̄) formation that limits NO availability. 12 In the inner ear, NoxO1 may interact with Nox3, which is involved in the proper formation of othoconia. 13 Mice expressing a dysfunctional mutant of NoxO1 indeed present with a similar phenotype as Nox3 −/− mice: both have major balance problems and a head-tilt phenotype. 14 In the vasculature, NoxO1 is primarily thought to activate Nox1, and thus most of its functions should be analogous to those of Nox1. Nox1 is a mediator of angiotensin II-induced hypertension and endothelial dysfunction. 15 Genetic deletion of Nox1 promotes angiogenesis in xenograft tumor models and after femoral artery ligation. 16, 17 Nox1 thus has opposing functions to Nox4, which rather promotes angiogenesis. 17 The basis of this difference is probably the fact that Nox4 produces H 2 O 2 , whereas Nox1 primarily generates O 2̄, which scavenges NO and results in peroxynitrite formation.
Based on these considerations, we speculate that NoxO1 limits angiogenesis and studied this and its underlying mechanisms in a newly generated NoxO1 knockout mouse and in cultured endothelial cells.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

NoxO1 Is Expressed in the Vascular System
To determine the contribution of NoxO1 to vascular function, a global knockout mouse was generated by deletion of exons 2 to 9 through homologous recombination in C57/BL6 stem cells according to the strategy outlined in Figure 1A by Artemis. Integration of the neomycin cassette and germ-line transmission was confirmed by Southern blot, and global knockout mice were generated by crossing with Cre-deleters. NoxO1 −/− mice were viable and showed the expected headtilt phenotype as consequence of the absence of otoliths (data not shown). qRT-PCR from the carotid artery of wild-type (WT) animals demonstrated NoxO1 mRNA expression in the endothelium and in the smooth muscle layer, whereas NoxO1 mRNA from the region exon 2 to 9 was not detected in vessels of knockout mice ( Figure I in the online-only Data Supplement). To determine whether mRNA expression in WT animals was sufficient to result in protein formation, a NoxO1 antibody was raised in rabbits that yielded only a low background signal after affinity purification ( Figure 1B ; Figure IB in the online-only Data Supplement). In the skeletal muscle of WT animals, the antibody gave basically no staining of the skeletal fibers; the capillary compartment, comprising endothelium and pericytes, in contrast, stained NoxO1 positive. Importantly, this staining was not observed in tissue from NoxO1 −/− mice ( Figure 1B ). Figure 1C) . Collectively, the findings suggest that NoxO1 is expressed in the murine vascular endothelium and contributes to basal O 2 ̄ formation.
NoxO1 Limits the Angiogenic Function of Murine Lung Endothelial Cells
To characterize the functional importance of NoxO1 in the vascular system, we focused on angiogenesis in cultured cells and in vivo. Proliferation of LEC from WT and NoxO1 −/− cells in response to serum was similar (Figure 2A) , and there was also no difference in the behavior of NoxO1 −/− and WT LEC in the matrigel tube formation assay ( Figure II in the online-only Data Supplement). As the latter assay, however, only reflects aspects of cell-cell interaction in a disintegrating network but not a true angiogenic response, endothelial sheet migration in the scratch wound assay was studied. Basal and VEGF-stimulated migration of NoxO1 −/− LECs was higher than that of WT LECs ( Figure 2B ). Moreover, in the spheroid outgrowth assay, NoxO1 −/− LECs produced more sprouts and longer tubes in response to VEGF than WT LECs ( Figure 2C 
NoxO1 Deficiency Accelerates Angiogenesis
Given that NoxO1 affects migration and spheroid outgrowth, it could be inferred that also retina angiogenesis in vivo is limited by this NADPH oxidase subunit. Indeed, retina vascularization was quicker in NoxO1 −/− pups than in WT pups ( Figure 3A) . Interestingly, retinae of NoxO1 −/− pups also exhibited a higher density of the vascular plexus with a higher number of branches than their WT littermates ( Figure 3B ). This combination may suggest a more tip-cell-like behavior of NoxO1 −/− than that of WT cells. To determine whether NoxO1 also limits pathophysiological angiogenesis in mice, the femoral artery ligation model was performed. Laser Doppler flow imaging revealed that restoration of flow was indeed faster in NoxO1 −/− mice when compared with their WT littermates ( Figure 3C ). This was most likely a consequence of a greater degree of angiogenesis: NoxO1 −/− mice had a slightly higher endothelial cell:muscle fiber ratio at baseline ( Figure 3D ), and this difference was much more pronounced after femoral artery ligation. NoxO1 mRNA expression was lower in the operated than in the control leg of WT animals ( Figure 3E ). The angiogenic phenotype was paralleled by corresponding differences in VEGF mRNA expression: VEGF mRNA expression in muscles of the control leg of NoxO1 −/− mice was higher than that of WT littermates 2 weeks after the operation. In WT animals, VEGF mRNA expression in muscles of the operated leg was still significantly higher than from the control leg. In NoxO1 −/− animals, in contrast, no difference in VEGF mRNA expression was detected at this late time point ( Figure 3F ). Interestingly, NoxO1 also had an impact on mononuclear angiogenic cells, which contribute to revascularization. 18 Two weeks after femoral artery ligation, the number of bone marrow resident mononuclear cells was reduced in NoxO1 −/− mice, whereas the number of angiogenic myeloid cells and circulating mononuclear cells was increased ( Figure IV in the online-only Data Supplement). Such a difference could be a reflection of a difference in the release of chemokines and mobilizing factors from the ischemic leg. Thus, NoxO1 deficiency results in increased angiogenesis, and this could be a consequence of enhanced VEGF expression and mobilization of angiogenic cells from the bone marrow.
NoxO1 Deficiency Results in Attenuated Notch Signaling
In order to determine the mechanistic basis of the increased angiogenesis after NoxO1 deletion, experiments in cultured LECs were performed. Given that NoxO1 deficiency increased migration of endothelial cells in culture and in vivo without affecting proliferation, we hypothesized that NoxO1 deficiency may promote an endothelial tip-cell phenotype. 19 Indeed, VEGF receptor 2 mRNA expression was elevated in NoxO1 −/− cells. This effect was a consequence of the deletion of NoxO1 as overexpression of NoxO1 in NoxO1 −/− LECs rescued the phenotype ( Figure 4A ). Other markers of tip cells, such as EGF receptor or MMP2 and 9, had increased levels of mRNA and activity (Figure VA-VC in the online-only Data Supplement). Importantly, the expression of angiopoietin 1, which in general is important for developmental angiogenesis, 20 was unchanged, as was the expression of angiopoietin 2, which is required for angiogenic sprouting and vascular regression 21 ( Figure VD in the online-only Data Supplement).
On such a basis, we focused on the Notch signaling system, which mediates tip-stalk cell specification. The protein abundance of the tip-cell marker and Notch ligand Deltalike 4 (DLL4) was higher in NoxO1 −/− cells than in WT cells ( Figure 4B ). Accordingly, expression of the Notch target gene, Hey, was lower in LEC of NoxO1 −/− mice than in WT LEC ( Figure 4C ). Importantly, overexpression of NoxO1 in NoxO1 −/− LEC increased Hey expression over the expression level of WT cells, suggesting that NoxO1 promotes Notch signaling ( Figure 4C ).
On stimulation with its agonist DLL4, the Notch receptor is cleaved by an α-and γ-secretase, and the free Notch intracellular domain (NICD), the cleaved part of the receptor, mediates further downstream signaling. Interestingly, when WT LECs were stimulated with DLL4, the abundance of NICD increased, whereas this was not the case in NoxO1 −/− LECs ( Figure 4D ). As Notch1 mRNA expression was rather higher than lower in NoxO1 −/− cells (data not shown), we speculate that potentially impairment of Notch cleavage is responsible for the attenuated Notch signaling in NoxO1 −/− LECs.
NoxO1 Knockout Promotes an Endothelial Tip-Cell Phenotype
To dissect the presentation of Notch ligand from Notch signaling in this system, we generated mixed spheroids of LECs from WT and NoxO1 −/− mice stained with cell tracker green or red, respectively. Subsequently, the number of WT and NoxO1 −/− cells at the tip position was counted ( Figure 4E ). Under native conditions, NoxO1 −/− contributed >80% of the tip cells. Importantly, in the presence of the γ-secretase inhibitor dibenzazepine, the number of WT tip cells increased, whereas the number of NoxO1 −/− tip cells remained constant, so that the distribution was similar between the 2 genotypes ( Figure 4F ). To validate this effect, we utilized cells from the naturally occurring NoxO1 mutant mouse.
14 Because of the genetic background of this strain, these animals were not suited for in vivo experiments, as the WT controls had a poor angiogenic response, which is also illustrated by the failure of the WT cells to sprout from spheroids under native conditions ( Figure 4G ). Dibenzazepine treatment, however, increased sprouting of WT cells. Similar as in the C57/BL6-strain, sprouting of NoxO1-mutant cells was much better, and dibenzazepine failed to affect this process. (Figure 4G ). Given that NoxO1 knockout and mutant cells were unresponsive to dibenzazepine, it seems that the tip-cell specification observed after loss of NoxO1 is a consequence of a failure to cleave the Notch receptor and thus to release NICD with no effect on the γ-secretase itself.
NoxO1 Maintains α-Secretase (ADAM10/17) Activity
To identify the possible mechanisms leading to attenuated Notch receptor cleavage, we focused on the sheddases. mRNA expression of the γ-secretase coactivators presenelin 1 and 2, as well as mRNA and protein of the α-secretase ADAM17/ TACE, was similar between WT and NoxO1 −/− LECs ( Figure  5A and 5B). Given that ADAM17/TACE also cleaves pro-TNFα to the active cytokine, we measured this active TNFα in the murine plasma after femoral artery ligation. Importantly, NoxO1 −/− mice had significantly lower TNFα plasma level than WT animals ( Figure 5C ), pointing to a potential defect in ADAM17/TACE activity after deletion of NoxO1. Myers et al 22 found that ROS facilitate activation of ADAM17/TACE. In pilot experiments in our hands, H 2 O 2 increased, whereas unspecific inhibition of all flavor enzymes, including NADPH oxidases by diphenylene iodonium (10 μmol/L), decreased ADAM17/TACE oxidation ( Figure VI in the online-only Data Supplement). Given the lower O 2̄ level in LECs of NoxO1 −/− mice, the impact of NoxO1 overexpression on ADAM17/ TACE oxidation was analyzed in human umbilical endothelial cells. NoxO1 overexpression had no effect on ADAM17/TACE expression but increased not only the formation of O 2̄ but also the activity of ADAM17/TACE (Figure VII in the onlineonly Data Supplement). Importantly, NoxO1 overexpressed tripled ADAM17 oxidation as observed by redox-BIAM labeling followed by ADAM17/TACE IP and streptavidin detection ( Figure 5D ). The remaining fraction of the NoxO1 overexpressing cells after immunoprecipitation contained less ADAM17/TACE when compared with GFP overexpressing cells suggesting a functional important amount of oxidation of the protein. These data demonstrate that NoxO1 overexpression promotes ADAM17/TACE oxidation. To determine whether NoxO1 also affects the activity of the α-secretase, cleavage of a fluorescence-tagged substrate was measured in LECs ( Figure 5E ). The absence of NoxO1 resulted in an ≈25% reduction of ADAM17/TACE activity ( Figure 5E ). To determine whether this response is specific for NoxO1, LECs from p47phox −/− and NoxO1-p47phox double knockout mice were also included in the assay. Whereas activity in the double knockout mice was similar to that of NoxO1 LECs, deletion of p47phox failed to reduce ADAM17/TACE activity. Thus, a basal ROS formation facilitated by NoxO1-dependent activation of a Nox enzyme results in ADAM17/ TACE oxidation and thus activation of this sheddase. Lack of NoxO1 results in attenuated ADAM17/TACE oxidation and less activation and thus attenuated Notch signaling. The consequence is a more tip-cell-like endothelial phenotype and enhanced angiogenesis.
Discussion
This study provides evidence that the cytosolic NADPH oxidase subunit NoxO1 limits both developmental and reparative angiogenesis. As a potential mechanism, we identified that NoxO1 is required to maintain α-secretase activity that is required for Notch signaling. Impaired Notch activity promotes endothelial migration and angiogenesis.
In the course of angiogenesis, tip cells pave a way for the following endothelial cells in the direction of a chemoattractant cue like a gradient of VEGF. 23 Tip cells produce factors, such as the Notch ligand DLL4, that promote the specification of the following cells into stalk cells. 24 Binding of DLL4 to the extracellular domain of the Notch receptor triggers a series of proteolytic cleavages of Notch. The first cleavage step is mediated by an α-secretase, a member of the disintegrin and metalloproteases (ADAM) family within the juxtamembrane region, 25 followed by a cleavage by a proteolytical active γ-secretase within the transmembrane domain. 26 As a consequence, the NICD is released and translocates to the nucleus where it activates the transcription factor CSL (CBF1/RBP-Jk/ Suppressor of Hairless/LAG-1) by displacing a corepressor. 27 In NoxO1-deficient cells, DLL4 expression was increased, whereas NICD release on DLL4 stimulation was reduced, indicating a defect in Notch receptor function. Accordingly, expression of Notch target genes, such as the basic helixloop-helix proteins Hairy/Enhancer of Split (Hes)-related protein Hey, was reduced. Proteins encoded by the Hes and Hey genes are, in turn, transcriptional repressors of both their own expression and further downstream genes. 24 Among others, activation of Notch results in the downregulation of VEGFR2, 23 which then may act as an off switch for sprouting angiogenesis. Here, we found an enhanced expression of VEGFR2 indicating a defect in Notch signaling that promotes a tip-cell-like phenotype.
NoxO1 was initially reported as a cytosolic subunit of the Nox1 28 complex, but it is now known that NoxO1 is also involved in the activation of Nox3. 29 Mutation of Nox3 results in a defect to form otoliths, 13 an effect also observed in the knockout mice generated for this study. NoxO1 can also facilitate Nox2 activation, but this is less efficient than the activation facilitated by p47phox. 30 NoxO1 lacks the autoinhibitory loop of p47phox and is therefore considered constitutively active. 31 In line with this, we observed a reduced basal ROS production in NoxO1-deficient cells. Why less O 2̄ formation did not lead to less H 2 O 2 formation in the present study is unclear. Obviously, extracellular H 2 O 2 release is dependent on the O 2̄ consumption by nitric oxide, the level of peroxidases and peroxiredoxin, and preliminary data from our group indeed suggests a reduced abundance of these antioxidants in NoxO1 knockout cells.
Despite its constitutive activity, human NoxO1-dependent ROS production can be further increased by phosphorylation of the protein at serine and threonine residues by protein kinase C or protein kinase A, at least in overexpressing systems. 8 Interestingly, the activation of protein kinase C, either by a G-protein-coupled receptor signal or by stimulation with phorbolester, has previously been reported to increased activity of ADAM17.
32,33 ADAM17, with the alternative name TACE, belongs to the metzincin family, requiring a zinc ion for their proteolytic activity. In these enzymes, the redox state of 2 highly conserved cysteinyl sulfhydryl groups (cysteine-X-X-cysteine) in the disintegrin domain of ADAM17 regulates activity. This domain is located extracellularly, and oxidation of both cysteine residues, C522XXC and C600XXC, is necessary for the full activity of ADAM17 for L-selectin shedding in human neutrophils. 34 Importantly, in the present study, overexpression of NoxO1 in human umbilical vein endothelial cells resulted in an increased oxidation of ADAM17. In contrast, overexpression or knockout of NoxO1 had no effect on the expression of ADAM17. In fact, NoxO1-mediated O 2̄ formation by NADPH oxidases occurs at the membrane 35 and therefore close to ADAM17 where these ROS potentially affect ADAM17 activity rather than its expression. The concept that metalloproteinases require limited oxidation to ensure full catalytic activity has been already proven by others. 36 In keeping with this concept, we found ADAM17 activity to be reduced in the absence of NoxO1. A consequence of the altered ADAM17 activity in the absence of a functional NoxO1, the level of TNFα was reduced in murine plasma in the hindlimb ischemia model.
In addition, in NoxO1 −/− endothelial cells, DLL4 expression was upregulated. DLL4 and subsequent signal transduction have been suggested to induce the expression and secretion of MMP2 in gastric cells. 37 Nevertheless, the increased abundance of MMP2 and MMP9 seen in this study is in line with an enhanced mobilization of endothelial precursors from the bone marrow and enhanced endothelial migration and angiogenesis. 38, 39 In conclusion, with this work, we provide evidence that the cytosolic subunit of the NADPH oxidase complex NoxO1 is expressed in endothelial cells where it enables the constitutive formation of O 2̄. In the absence of NoxO1, angiogenesis is enhanced, indicating that NoxO1-mediated ROS formation limits angiogenesis. The latter is facilitated by the ability of NoxO1-dependent ROS formation to maintain α-secretase ADAM17 active 22 and thereby to allow a Notchdependent signal transduction. Consequently, in the absence of NoxO1, the phenotype of endothelial cells is switched to tip cells, rather than to stalk cells, which then promotes sprouting angiogenesis.
